If You’re Vaccinated, You Can Live Your Life Again. It

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks
233
If You’re Vaccinated, You Can Live Your Life Again. It Really Is That Simple.

The evidence suggests vaccines don't just prevent death and serious disease, they significantly reduce transmission. Maybe the time has come for people to make their own choices for their lives.


https://www.esquire.com/news-politics/a363816...nl23766679

_By Jack Holmes
May 10, 2021

By late April, at a time when more than 95 million people in the United States had been vaccinated against COVID-19, the Centers for Disease Control said it had received reports of 9,245 "breakthrough infections." These are cases where a fully vaccinated person still managed to contract the disease.

This was probably something of an undercount, the CDC clarified, because it "relies on voluntary reporting from state health departments which may not be complete. Also, not all real-world breakthrough cases will be identified because of lack of testing." But even if the real number of breakthroughs was 10 times the number we know of—90,000 vs. 9,000—it would still represent a minuscule percentage of those vaccinated.

This echoes what the CDC reported in early April: "a growing body of evidence suggests that COVID-19 vaccines may also reduce asymptomatic infection, and potentially transmission." Because the vaccines seem to largely prevent people from getting this thing at all, most won't pass it on to others, either.

There was also some evidence of this from the various vaccine manufacturers' clinical trials, even if monitoring this aspect took a backseat to examining the prevention of severe disease. Pfizer-BioNTech, Moderna, and Johnson & Johnson all reported big drops in asymptomatic infections among those vaccinated: J&J estimated a 74 percent reduction, while Pfizer came in at 85 to 89 percent.

Another study found that people who'd had just one dose of the Pfizer vax had "viral loads" up to 20 times lower than unvaccinated people who contracted the disease, suggesting that even if you do pick up the virus, you're not carrying nearly as much of it—and thus are less likely to pass it to other people. This is the subtext of the calls from health officials for you to get vaccinated "to protect yourself and others."

All of this is in addition to the baseline finding that the vaccines prevent almost all hospitalization and death (of those 95 million vaccinated in the CDC report above, there were 825 reported hospitalizations, and a quarter of those were asymptomatic or not COVID-related), and that they continue to be effective against known "variants of concern"—like the London or South African or Brazilian strains—they've studied.

(BioNTech said Monday that it currently sees "no evidence" that it will need to adapt the vax it developed with Pfizer to combat any new variants, though it is making preparations in that regard. Moderna seems to be farther along on that front.)

Barring the development of some Super Strain that evades these protections, it seems like the news is...quite good indeed. If you get vaccinated, it is vanishingly unlikely that you will get severe symptoms, have to be hospitalized, or die.

In fact, it is looking more and more unlikely that you will contract the disease at all, or in enough of a viral concentration that you are at major risk of passing it to other people. One principle for life in a free society is that if you're not infringing on the rights of other people, you're usually good to do what you're doing.

Which made the TV testimony of former FDA chief and current Pfizer board member Scott Gottlieb seem pretty reasonable on Monday morning.

"We should be lifting the mask ordinances outside in a wholesale fashion, I think we should be lifting them in indoor settings as well in many states," says @ScottGottliebMD. "We've hit our own goal--we just are reluctant to relax the measures now." pic.twitter.com/BHoGLi4B25
— Squawk Box (@SquawkCNBC) May 10, 2021

This was in line with what he had to say on Thursday of last week:

"I think we can do it right around now," @ScottGottliebMD says on lifting indoor mask mandates. pic.twitter.com/weVu2jTo0q
— The News with Shepard Smith (@thenewsoncnbc) May 6, 2021

We are at the point where we need to convince the unenthused to get vaccinated, and while there are many tools in the toolkit—apparently, free beer stays undefeated—a big one surely must be a big neon sign that says, "YOU GET YOUR LIFE BACK."

If at-risk people will be protected from hospitalization and death, and if, as increasingly seems to be the case, very few among the vaccinated will even be contracting or spreading the disease, there is a building scientific basis for the idea that masks for vaccinated people are unnecessary.

But it's also crucial in demonstrating to people the real value of vaccines: they will get us back to the things we want to do. It's understandable that the CDC approaches this with caution, and maybe there's a basis for masks in grocery stores and shops, and on public transportation, for a little while longer. Certainly, we can hope that masks on buses and planes and the subway become a durable social norm during flu season.

In fact, as more and more people get vaccinated, COVID is becoming more like the flu—or even the common cold. It was wrong for people to make the comparison early on in the pandemic, but it's becoming more and more apt.

Yet we're still getting headlines from the Paper of Record about how herd immunity is now out of reach for our society, complete with warnings that the disease will be "an ever-present threat." (Monday saw the second such headline in the space of the week, though the first article clarified that it will be a "manageable threat."

Herd immunity is not necessary to get back to our lives. We just need to stop people dying from this disease, which the vaccines do. This novel coronavirus may never be eradicated completely, and that's fine. Some forms of the common cold are coronaviruses that once may have wreaked havoc on our species.

We adapt. We've used the incredible ingenuity of our species to change our relationship to this pathogen in record time. Human beings have engineered a scientific miracle, one we should celebrate by adapting the rules of our pandemic response as the evidence indicates.

The longer we wait to adapt our standards, though, the more the credibility of public-health experts (and the press) takes on damage, just as Gottlieb suggested. I've seen it anecdotally in talking to people who generally defer to public-health recommendations, but who view the framing of these discussions as increasingly absurd.

On the media side, the thirst among some news consumers for so-called "Doombait," and the willingness among outlets to supply it, does not seem to have waned as fast as the numbers of cases, hospitalizations, and deaths.

Dr. Anthony Fauci voiced some support for Gottlieb's position on Sunday, though he stressed he feels national case levels are still too high. (That gets at Gottlieb's other point, about adjusting rules by jurisdiction depending on local prevalence.)


But then his interviewer, George Stephanopoulos, started asking Fauci about what "next Mother's Day" is going to look like. George, my man. We're headed towards a normal summer. We're all shook up from this period in our lives, but we have to ditch some of the calcified assumptions we've developed in that time. Reuters created an entire interactive PAC-MAN-style graphic around the return-to-office, in which the goal seems to be to never interact with any of your coworkers under any circumstances.

Folks, we're going to be vaxxed up. You can chat with your friends at work. We need to dial back the absolutism, or many people will absolutely stop paying attention.

We’re getting to a place where you can choose to do what you’re comfortable with, safe in the knowledge it is unlikely you will get yourself or others sick.


We are getting towards the stage where life is, once again, a choose-your-own-adventure: if you are still wary, you can continue limiting your contacts. (Many people have not had that luxury at any point in this era.) But if you are ready to get back to life, you can do so in good standing, confident that you will not get very sick and die, and increasingly confident that you cannot pass the pathogen on to others.

The potential for new variants to develop and get around the vaccines is frightening, especially as COVID ravages other countries, like India, and the United States is only beginning to get doses to the rest of the world.

Where COVID is spreading, it's mutating. The Biden administration has signaled its support for loosening patent protections on the vaccines on an emergency basis so other countries can mass-manufacture their own doses, though it's unclear what the timeframe is on that.

But we are getting to a place in this country where we can start to do the things that make life worth living again. We must honor those we lost, and acknowledge that we lost more than we should have, and learn from that. But it's hard to believe that anyone who died from this vicious disease would want we, the living, to delay going back to some of the best things in life longer than is necessary.

We can honor them with monuments and remembrances, but we can also honor them by enjoying ourselves. Raise a glass—your free vaccination beer, maybe—with a promise to devote yourself to a life well-lived. As it stands, I intend to go to some concerts this summer. Maybe even a club.

That doesn't mean you have to do the same. If being vaccinated means you are not putting others at risk, and this lack of spread means cases and hospitalizations and deaths continue to drop, it's time to choose your own path through the world, just like you did a year and a half ago.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Updated Category News Views 2

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Continue Reading
Veho's Role in Redefining Beauty E-Commerce Delivery

Updated Category News Views 1

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Continue Reading
Push Notification Security Transforms Healthcare IT Support

Updated Category News Views 2

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 3

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Shareholder Rights in Focus: Examining Key Buyouts

Updated Category News Views 2

Shareholder Concerns Rise Amid Corporate Buyouts The stakes are high for the shareholders of Distribution Solutions Group, Eagle Financial Services, Safety Insurance Group, and Utz Brands as their companies face potential buyouts. Let's chew over what's on the table: the sweet deals insiders might score and the legal maneuvers in play. Halper Sadeh LLC, a heavy-hitting...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 2

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Cove Capital Secures $9.96M for Debt-Free Logistics DST

Updated Category News Views 1

Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...

Continue Reading
RARE Foundation Rebrands, Focus Still Strong

Updated Category News Views 2

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Continue Reading
Hair Syrup's Big U.S. Leap: Target Welcomes Viral Brand

Updated Category News Views 2

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 1

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading

Top 5 Most Recently Viewed Articles

Appiphony's Parse Connect: Game-Changer for Salesforce Users

Updated Category News Views 228

The Shift in Document Processing Listen, if you’ve been in this game long enough, you've seen the headache of manual data entry—it’s like a bad dream that just won't end. But fear not, because Appiphony's just dropped Parse Connect on Salesforce AppExchange, and it looks to sort out some of that mess. This new tool enables businesses to take unstructured content and...

Continue Reading
Wolters Kluwer Annual Report 2024: Solid Growth Insights

Updated Category News Views 1337

Wolters Kluwer 2024 Financial Highlights Wolters Kluwer, a prominent global leader in providing professional information solutions, announced substantial financial results for the year 2024. With revenues reaching €5,916 million, the company experienced a 6% increase in constant currencies and a 6% organic growth rate, solidifying its position in the market. Revenue...

Continue Reading
Understanding Card Payment Surcharges Among Small Businesses

Updated Category News Views 193

Rising Surcharges on Card Payments in Small Businesses Recent research has unveiled that many small businesses are taking a more cautious approach regarding their financial futures. As company owners are adapting to an evolving payment landscape filled with debit and credit cards, digital wallets, and even cryptocurrencies, a notable trend has emerged: the addition of...

Continue Reading
Nuvectis Pharma’s Q3 2025: Strategic Developments Unveiled

Updated Category News Views 114

Nuvectis Pharma, Inc.: Q3 2025 Financial Highlights Nuvectis Pharma, Inc. (NASDAQ: NVCT), a pioneering biopharmaceutical enterprise, has made considerable strides in its mission to develop cutting-edge precision medicines for oncology. Recently, the company unveiled its financial results for the third quarter of 2025, alongside exciting updates on its clinical programs....

Continue Reading
Porter Airlines Launches Exciting Nonstop Routes to Florida

Updated Category News Views 233

Porter Airlines Expands Horizons with New Florida Flights Porter Airlines is making headlines as it launches two exciting nonstop routes from Halifax Stanfield International Airport to Florida. This marks a significant milestone for Porter, as it will be the first time the airline operates direct flights to the United States from Halifax, creating a direct connection to...

Continue Reading